{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:34:13Z","timestamp":1775885653000,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070251"],"award-info":[{"award-number":["82070251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070252"],"award-info":[{"award-number":["82070252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["LR21H020001"],"award-info":[{"award-number":["LR21H020001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies have shown an association between gut microbiota and cardiovascular diseases (CVDs). However, the underlying causal relationship remains unclear. This study aims to elucidate the causal relationship between gut microbiota and CVDs and to explore the pathogenic role of gut microbiota in CVDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this two-sample Mendelian randomization study, we used genetic instruments from publicly available genome-wide association studies, including single-nucleotide polymorphisms (SNPs) associated with gut microbiota (<jats:italic>n<\/jats:italic>\u2009=\u200914,306) and CVDs (<jats:italic>n<\/jats:italic>\u2009=\u20092,207,591). We employed multiple statistical analysis methods, including inverse variance weighting, MR Egger, weighted median, MR pleiotropic residuals and outliers, and the leave-one-out method, to estimate the causal relationship between gut microbiota and CVDs. Additionally, we conducted multiple analyses to assess horizontal pleiotropy and heterogeneity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>GWAS summary data were available from a pooled sample of 2,221,897 adult and adolescent participants. Our findings indicated that specific gut microbiota had either protective or detrimental effects on CVDs. Notably, Howardella (OR\u2009=\u20090.955, 95% CI: 0.913\u20130.999, <jats:italic>P<\/jats:italic>\u2009=\u2009.05), Intestinibacter (OR\u2009=\u20090.908, 95% CI:0.831\u20130.993, <jats:italic>P<\/jats:italic>\u2009=\u2009.03), Lachnospiraceae (NK4A136 group) (OR\u2009=\u20090.904, 95% CI:0.841\u20130.973, <jats:italic>P<\/jats:italic>\u2009=\u2009.007), Turicibacter (OR\u2009=\u20090.904, 95% CI: 0.838\u20130.976, <jats:italic>P<\/jats:italic>\u2009=\u2009.01), Holdemania (OR, 0.898; 95% CI: 0.810\u20130.995, <jats:italic>P<\/jats:italic>\u2009=\u2009.04) and Odoribacter (OR, 0.835; 95% CI: 0.710\u20130.993, <jats:italic>P<\/jats:italic>\u2009=\u2009.04) exhibited a protective causal effect on atrial fibrillation, while other microbiota had adverse causal effects. Similar effects were observed with respect to coronary artery disease, myocardial infarction, ischemic stroke, and hypertension. Furthermore, reversed Mendelian randomization analyses revealed that atrial fibrillation and ischemic stroke had causal effects on certain gut microbiotas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study underscored the importance of gut microbiota in the context of CVDs and lent support to the hypothesis that increasing the abundance of probiotics or decreasing the abundance of harmful bacterial populations may offer protection against specific CVDs. Nevertheless, further research is essential to translate these findings into clinical practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13040-024-00356-2","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T17:02:19Z","timestamp":1708966939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Assessment of the causal relationship between gut microbiota and cardiovascular diseases: a bidirectional Mendelian randomization analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiao-Ce","family":"Dai","sequence":"first","affiliation":[]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Si-Yu","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Shuo","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Mei-Xiang","family":"Xiang","sequence":"additional","affiliation":[]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"10015","key":"356_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","volume":"387","author":"M Zhou","year":"2016","unstructured":"Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2016;387(10015):251\u201372.","journal-title":"Lancet (London, England)"},{"issue":"9882","key":"356_CR2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","volume":"381","author":"G Yang","year":"2013","unstructured":"Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2013;381(9882):1987\u20132015.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"356_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"356_CR4","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1038\/s41598-022-08544-y","volume":"12","author":"H Shi","year":"2022","unstructured":"Shi H, Ter Horst R, Nielen S, et al. The gut microbiome as mediator between diet and its impact on immune function. Sci Rep. 2022;12(1):5149.","journal-title":"Sci Rep"},{"issue":"11","key":"356_CR5","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.3390\/nu12113239","volume":"12","author":"O Ojo","year":"2020","unstructured":"Ojo O, Feng QQ, Ojo OO, Wang XH. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Nutrients. 2020;12(11):3239.","journal-title":"Nutrients"},{"issue":"7","key":"356_CR6","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1210\/clinem\/dgac210","volume":"107","author":"X Deng","year":"2022","unstructured":"Deng X, Zhang C, Wang P, et al. Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes. J Clin Endocrinol Metab. 2022;107(7):1888\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"356_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12944-022-01702-1","volume":"21","author":"VH Telle-Hansen","year":"2022","unstructured":"Telle-Hansen VH, Gaundal L, Bastani N, et al. Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels-a randomized controlled trial in healthy individuals. Lipids Health Dis. 2022;21(1):92.","journal-title":"Lipids Health Dis"},{"issue":"7341","key":"356_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"issue":"12","key":"356_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cjca.2014.09.010","volume":"30","author":"M Ufnal","year":"2014","unstructured":"Ufnal M, Jazwiec R, Dadlez M, Drapala A, Sikora M, Skrzypecki J. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can J Cardiol. 2014;30(12):1700\u20135.","journal-title":"Can J Cardiol"},{"issue":"1","key":"356_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ajcn\/nqac074","volume":"116","author":"D Li","year":"2022","unstructured":"Li D, Lu Y, Yuan S, et al. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am J Clin Nutr. 2022;116(1):230\u201343.","journal-title":"Am J Clin Nutr"},{"issue":"5717","key":"356_CR11","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F B\u00e4ckhed","year":"2005","unstructured":"B\u00e4ckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science (New York, NY). 2005;307(5717):1915\u201320.","journal-title":"Science (New York, NY)"},{"issue":"11","key":"356_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/ajcn\/23.11.1495","volume":"23","author":"DC Savage","year":"1970","unstructured":"Savage DC. Associations of indigenous microorganisms with gastrointestinal mucosal epithelia. Am J Clin Nutr. 1970;23(11):1495\u2013501.","journal-title":"Am J Clin Nutr"},{"issue":"44","key":"356_CR13","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"356_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","volume":"122","author":"SK Mazmanian","year":"2005","unstructured":"Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107\u201318.","journal-title":"Cell"},{"issue":"6","key":"356_CR15","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1073\/pnas.0712038105","volume":"105","author":"M Li","year":"2008","unstructured":"Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA. 2008;105(6):2117\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"356_CR16","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.18632\/aging.202763","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang H, Ren S, Lv H, Cao L. Gut microbiota from mice with cerebral ischemia-reperfusion injury affects the brain in healthy mice. Aging. 2021;13(7):10058\u201374.","journal-title":"Aging"},{"key":"356_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcimb.2020.00018","volume":"10","author":"S Wan","year":"2020","unstructured":"Wan S, Nie Y, Zhang Y, Huang C, Zhu X. Gut microbial dysbiosis is associated with profibrotic factors in liver fibrosis mice. Front Cell Infect Microbiol. 2020;10:18.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"356_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845.","journal-title":"Nat Commun"},{"issue":"16","key":"356_CR19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WHW Tang","year":"2019","unstructured":"Tang WHW, B\u00e4ckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(16):2089\u2013105.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"356_CR20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"2","key":"356_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"R2","key":"356_CR22","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey SG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195\u2013r208.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"356_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"356_CR24","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"356_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"6","key":"356_CR26","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111(6):2247\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"356_CR27","first-page":"1569","volume":"20","author":"K Kim","year":"2019","unstructured":"Kim K, Kwon O, Ryu TY, et al. Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer. Mol Med Rep. 2019;20(2):1569\u201374.","journal-title":"Mol Med Rep"},{"issue":"3","key":"356_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s10620-020-06106-8","volume":"65","author":"RS Chapkin","year":"2020","unstructured":"Chapkin RS, Navarro SL, Hullar MAJ, Lampe JW. Diet and gut microbes act coordinately to enhance programmed cell death and reduce colorectal cancer risk. Dig Dis Sci. 2020;65(3):840\u201351.","journal-title":"Dig Dis Sci"},{"issue":"39","key":"356_CR29","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","volume":"38","author":"GG Schiattarella","year":"2017","unstructured":"Schiattarella GG, Sannino A, Toscano E, et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J. 2017;38(39):2948\u201356.","journal-title":"Eur Heart J"},{"issue":"1","key":"356_CR30","doi-asserted-by":"publisher","first-page":"e009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","volume":"16","author":"KA Romano","year":"2023","unstructured":"Romano KA, Nemet I, Prasad Saha P, et al. Gut microbiota-generated phenylacetylglutamine and heart failure. Circ Heart Fail. 2023;16(1):e009972.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"356_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1210\/clinem\/dgaa644","volume":"106","author":"Y Guo","year":"2021","unstructured":"Guo Y, Luo S, Ye Y, Yin S, Fan J, Xia M. Intermittent fasting improves cardiometabolic risk factors and alters gut microbiota in metabolic syndrome patients. J Clin Endocrinol Metab. 2021;106(1):64\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"356_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/art.42331","volume":"75","author":"L Fan","year":"2023","unstructured":"Fan L, Chen J, Pan L, et al. Alterations of gut microbiome, metabolome, and lipidome in Takayasu arteritis. Arthritis Rheumatol (Hoboken, NJ). 2023;75(2):266\u201378.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"10","key":"356_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/biom12101445","volume":"12","author":"C Fang","year":"2022","unstructured":"Fang C, Zuo K, Fu Y, et al. Aggravated gut microbiota and metabolomic imbalances are associated with hypertension patients comorbid with atrial fibrillation. Biomolecules. 2022;12(10):1445.","journal-title":"Biomolecules"},{"key":"356_CR34","doi-asserted-by":"publisher","first-page":"7942605","DOI":"10.1155\/2022\/7942605","volume":"2022","author":"C Fang","year":"2022","unstructured":"Fang C, Zuo K, Zhang W, et al. Association between gut microbiota dysbiosis and the CHA2DS2-VASc score in atrial fibrillation patients. Int J Clin Pract. 2022;2022:7942605.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"356_CR35","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li M, Chen Q, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13(1):3432.","journal-title":"Nat Commun"},{"key":"356_CR36","doi-asserted-by":"publisher","first-page":"667097","DOI":"10.3389\/fimmu.2021.667097","volume":"12","author":"K Xiang","year":"2021","unstructured":"Xiang K, Wang P, Xu Z, et al. Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample Mendelian randomization study. Front Immunol. 2021;12:667097.","journal-title":"Front Immunol"},{"key":"356_CR37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fmicb.2017.01687","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Liu HY, Zhou H, et al. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 2017;8:1687.","journal-title":"Front Microbiol"},{"issue":"7484","key":"356_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559\u201363.","journal-title":"Nature"},{"key":"356_CR39","doi-asserted-by":"publisher","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","volume":"335","author":"S Paul","year":"2021","unstructured":"Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518.","journal-title":"Exp Neurol"},{"key":"356_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jnutbio.2018.12.004","volume":"65","author":"R Chen","year":"2019","unstructured":"Chen R, Wu P, Cai Z, et al. Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biochem. 2019;65:101\u201314.","journal-title":"J Nutr Biochem"},{"key":"356_CR41","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yang F, Cao J, et al. Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb Pathog. 2021;160:105187.","journal-title":"Microb Pathog"},{"issue":"1","key":"356_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/cancers15010192","volume":"15","author":"S Rezasoltani","year":"2022","unstructured":"Rezasoltani S, Aghdaei HA, Jasemi S, et al. Oral microbiota as novel biomarkers for colorectal cancer screening. Cancers. 2022;15(1):192.","journal-title":"Cancers"},{"issue":"1","key":"356_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, Ni Y, Wang Z, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut microbes. 2020;12(1):1\u201319.","journal-title":"Gut microbes"},{"key":"356_CR44","doi-asserted-by":"publisher","first-page":"1167346","DOI":"10.3389\/fcvm.2023.1167346","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Fu R, Li R, et al. Causality of gut microbiome and hypertension: a bidirectional mendelian randomization study. Front Cardiovasc Med. 2023;10:1167346.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"356_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40168-021-01002-3","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, Xu Z, Han W, et al. HMD-ARG: hierarchical multi-task deep learning for annotating antibiotic resistance genes. Microbiome. 2021;9(1):40.","journal-title":"Microbiome"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00356-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-024-00356-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00356-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T08:05:23Z","timestamp":1709021123000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-024-00356-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/s13040-024-00356-2","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}